These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 20169902

  • 1. [Role of complement system in the pathogenesis of AMD].
    Machalińska A, Karczewicz D.
    Klin Oczna; 2009; 111(10-12):384-7. PubMed ID: 20169902
    [Abstract] [Full Text] [Related]

  • 2. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A, Kavanagh D, Atkinson JP.
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [Abstract] [Full Text] [Related]

  • 3. Inflammation and the pathogenesis of age-related macular degeneration.
    Augustin AJ, Kirchhof J.
    Expert Opin Ther Targets; 2009 Jun; 13(6):641-51. PubMed ID: 19456269
    [Abstract] [Full Text] [Related]

  • 4. The complement system and age-related macular degeneration.
    Sivaprasad S, Chong NV.
    Eye (Lond); 2006 Aug; 20(8):867-72. PubMed ID: 16410816
    [Abstract] [Full Text] [Related]

  • 5. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ, Hamon SC, Ott J, Weleber RG, Klein ML.
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
    Tan JS, Mitchell P, Smith W, Wang JJ.
    Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
    [Abstract] [Full Text] [Related]

  • 7. [Genetic aspects of age-related macular degeneration].
    Janik-Papis K, Zaraś M, Skłodowska A, Ulińska M, Borucka AI, Błasiak J.
    Klin Oczna; 2009 Jun; 111(4-6):178-82. PubMed ID: 19673454
    [Abstract] [Full Text] [Related]

  • 8. Age-related macular degeneration: an immunologically driven disease.
    Nussenblatt RB, Liu B, Li Z.
    Curr Opin Investig Drugs; 2009 May; 10(5):434-42. PubMed ID: 19431076
    [Abstract] [Full Text] [Related]

  • 9. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice.
    Ambati J, Anand A, Fernandez S, Sakurai E, Lynn BC, Kuziel WA, Rollins BJ, Ambati BK.
    Nat Med; 2003 Nov; 9(11):1390-7. PubMed ID: 14566334
    [Abstract] [Full Text] [Related]

  • 10. Methodology of the Cardiovascular Health and Age-Related Maculopathy (CHARM) Study.
    Robman L, McNeil J, Dimitrov P, Dowrick A, Tikellis G, Nicolas C, Cameron J, Guymer R, McGrath B, McCarty C.
    Ophthalmic Epidemiol; 2004 Jul; 11(3):161-79. PubMed ID: 15370549
    [Abstract] [Full Text] [Related]

  • 11. [Age-related macular degeneration--a complex genetic disease].
    Antoniak K, Bienias W, Nowak JZ.
    Klin Oczna; 2008 Jul; 110(4-6):211-8. PubMed ID: 18655465
    [Abstract] [Full Text] [Related]

  • 12. Age-related macular degeneration: a leading cause of blindness.
    O'Shea JG.
    Med J Aust; 1996 Nov 18; 165(10):561-4. PubMed ID: 8941243
    [Abstract] [Full Text] [Related]

  • 13. Two genetic pathways for age-related macular degeneration.
    DeWan A, Bracken MB, Hoh J.
    Curr Opin Genet Dev; 2007 Jun 18; 17(3):228-33. PubMed ID: 17467263
    [Abstract] [Full Text] [Related]

  • 14. [Risk factors in age-related macular degeneration and glaucoma--own observations].
    Wierzbowska J, Figurska M, Stankiewicz A, Sierdziński J.
    Klin Oczna; 2008 Jun 18; 110(10-12):370-4. PubMed ID: 19195169
    [Abstract] [Full Text] [Related]

  • 15. Age-related macular degeneration and mortality from cardiovascular disease or stroke.
    Tan JS, Wang JJ, Liew G, Rochtchina E, Mitchell P.
    Br J Ophthalmol; 2008 Apr 18; 92(4):509-12. PubMed ID: 18310310
    [Abstract] [Full Text] [Related]

  • 16. Immunological factors in the pathogenesis and treatment of age-related macular degeneration.
    Kijlstra A, La Heij E, Hendrikse F.
    Ocul Immunol Inflamm; 2005 Feb 18; 13(1):3-11. PubMed ID: 15804763
    [Abstract] [Full Text] [Related]

  • 17. Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients.
    Alexander SL, Linde-Zwirble WT, Werther W, Depperschmidt EE, Wilson LJ, Palanki R, Saroj N, Butterworth SL, Ianchulev T.
    Ophthalmology; 2007 Dec 18; 114(12):2174-8. PubMed ID: 18054636
    [Abstract] [Full Text] [Related]

  • 18. [Eye's risk factors in age-related macular degeneration (AMD). Part II].
    Drobek-Słowik M, Karczewicz D, Safranow K.
    Klin Oczna; 2008 Dec 18; 110(1-3):44-9. PubMed ID: 18669083
    [Abstract] [Full Text] [Related]

  • 19. Inflammatory biomarkers for AMD.
    Stanton CM, Wright AF.
    Adv Exp Med Biol; 2014 Dec 18; 801():251-7. PubMed ID: 24664705
    [Abstract] [Full Text] [Related]

  • 20. [Eye's risk factors in age-related macular degeneration (AMD). Part I].
    Drobek-Słowik M, Karczewicz D, Safrano K.
    Klin Oczna; 2008 Dec 18; 110(1-3):40-3. PubMed ID: 18669082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.